Colgate-Palmolive (CL) Tops Q2 EPS by 4c

Go back to Colgate-Palmolive (CL) Tops Q2 EPS by 4c

Colgate-Palmolive Company (CL) PT Raised to $115 at TD Cowen

July 29, 2024 1:10 PM UTC

TD Cowen analyst Robert Moskow raised the price target on Colgate-Palmolive Company (NYSE: CL) to $115.00 (from $110.00) while maintaining a Buy rating.

The analyst comments "Colgate delivered a high quality 2Q and raised guidance meaningfully. Consistent with our positive thesis, volume growth continued to... More

Colgate-Palmolive Company (CL) PT Raised to $101 at Jefferies

July 29, 2024 6:06 AM UTC

Jefferies analyst Kaumil Gajrawala raised the price target on Colgate-Palmolive Company (NYSE: CL) to $101.00 (from $95.00) while maintaining a Hold rating.

The analyst comments "Colgate had to deliver a perfect qtr to sustain its 27x NTM P/E multiple. They did. Brand reinvestments are working,... More

Colgate-Palmolive Company (CL) PT Raised to $112 at Evercore ISI

July 29, 2024 5:34 AM UTC

Evercore ISI analyst Robert Ottenstein raised the price target on Colgate-Palmolive Company (NYSE: CL) to $112.00 (from $106.00) while maintaining a Outperform rating.

The analyst comments "Friday, Colgates shares closed at a 30% premium to Staples, 5 points above its 20-year trading range. We do not expect CL to regress... More

Stifel on Colgate-Palmolive Company (CL): 'Lifting Estimates on Solid 2Q with Volume, EBIT Outperformance'

July 26, 2024 2:20 PM UTC

Stifel analyst Mark Astrachan reiterated a Buy rating and $105.00 price target on Colgate-Palmolive Company (NYSE: CL).

The analyst comments "We lift 2024-2025 EPS estimates and maintain our Buy rating and $105 price target, 17x 2025E EBITDA, following strong 2Q24 results with sales and... More